The invention relates to a medical chewing gum comprising gum base polymers and one or more cannabinoids as an active pharmaceutical ingredient, the gum base polymers comprising polyvinyl acetate and vinyl laurate-vinyl acetate copolymer in an amount of more than 90% by weight of the gum base polymers, wherein the gum basepolymers include 20 -95% by weight of polyvinyl acetate and -80% by weight of vinyl laurate-vinyl acetate copolymer.